quinoxalines has been researched along with celastrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beal, MF; Faust, K; Gehrke, S; Lu, B; Yang, L; Yang, Y | 1 |
| Idris, AI; Krishnan, M; Landao-Bassonga, E; Mollat, P; Ralston, SH; Simic, P; Vukicevic, S | 1 |
2 other study(ies) available for quinoxalines and celastrol
| Article | Year |
|---|---|
Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease.
Topics: Age Factors; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents; Antioxidants; Brain; Cell Count; Cell Survival; Chromatography, High Pressure Liquid; Dopamine; Drosophila; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Immunohistochemistry; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Pentacyclic Triterpenes; Quinoxalines; Triterpenes; Ubiquinone | 2009 |
Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Resorption; Cell Differentiation; Cell Survival; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Female; Humans; I-kappa B Kinase; Imidazoles; Inhibitory Concentration 50; Mice; Osteoclasts; Ovariectomy; Pentacyclic Triterpenes; Quinoxalines; Sesquiterpenes; Signal Transduction; Triterpenes | 2010 |